who has a rare genetic disorder called tuberous sclerosis. Oakland mayor and county’s district attorney ousted in historic ...

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and ...

It’s pumpkin pie up North, sweet potato pie down South. What’s the difference and which is better? A horticulturist at ...

The tuberous roots of daylilies make them very ... Seed heads provide winter interest and food for foraging birds. By avoiding cutbacks altogether or trimming perennials shorter instead of cutting ...

The company is currently waiting to release Phase 3 Food and Drug Administration (FDA) results for its drug ganaxalone. The drug aims to treat Tuberous Sclerosis Complex (TSC). If approved ...

Marinus Pharmaceuticals has reported that the Phase III TrustTSC trial of oral ganaxolone in treating seizures linked to ...

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, announced that the U.S. Food and Drug Administration ... type 2 (FCD T2) and tuberous sclerosis complex ...

Among these treasures, your eye catches a curious sight — a tuberous, brown-hued root of intriguing length ... You’ve just made your favorite comfort food—a warm “sancochado,” a Peruvian soup ...

Scales are modified leaves and contain necessary food to sustain the bulb during its dormancy and ... Plants that grow from bulblike organs are corms, tubers, rhizomes, and tuberous roots. Some bulbs ...

Eating foods, like sweet potatoes ... are a powerhouse of nutrition and an excellent addition to nearly any diet. The antioxidants in the tuberous vegetable contain many health benefits, including by ...

Last month, a second phase 3 blow for Marinus Pharmaceuticals prompted the Pennsylvania-based drugmaker to turn an eye toward ...

The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, ...